Top Institutions in Ophthalmology, Retinal Diseases
Ranking is based on institutional leadership in retinal disease research, clinical trials of novel therapeutics including TKIs and anti-VEGF agents, and contributions to understanding retinal vascular pathophysiology and drug development.
-
#1
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with extensive clinical trials in retinal diseases, pioneering research in anti-VEGF therapies, and active investigation into novel treatments including TKIs for retinal vascular disorders.
-
#2
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
Massachusetts Eye and Ear has a robust retinal research program with leadership in clinical trials of anti-VEGF agents and emerging therapies, including TKIs, and a strong focus on molecular mechanisms of retinal vascular diseases.
-
#3
Wills Eye Hospital, Thomas Jefferson University
Philadelphia, PA
Wills Eye is renowned for its clinical expertise in retinal diseases and extensive involvement in clinical trials evaluating new treatments including TKIs and sustained delivery systems for nAMD and DME.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a comprehensive research program in retinal vascular diseases, focusing on molecular pathways and novel therapeutics including TKIs, with a history of translating basic science discoveries into clinical trials.
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a leading ophthalmology department with active research in retinal diseases, including clinical trials of novel agents such as TKIs and innovative drug delivery systems to improve treatment outcomes in nAMD and DME.